期刊文献+

阵发性睡眠性血红蛋白尿患者尿激酶受体的表达及临床意义 被引量:2

Expression of urokinase-type plasminogen activator receptor in paroxysmal nocturnal hemoglobinuria and its clinical implications
下载PDF
导出
摘要 目的:检测尿激酶型纤溶酶原激活物受体在阵发性睡眠性血红蛋白尿(PNH)患者中的表达,并探讨其与PNH诊断以及血栓形成的关系。方法:PNH患者22例,其中4例伴血栓形成;单纯心/脑血栓形成患者20例;健康志愿者20例。以流式细胞术检测外周血粒细胞上CD87的表达,ELISA法检测血清可溶性尿激酶受体(su鄄PAR)。结果:健康志愿者外周血CD87+粒细胞比例皆>90%,单纯心/脑血栓形成组与健康志愿者组表达率差异无统计学意义。与其他两组相比,PNH患者外周血CD87+粒细胞百分率显著降低(P<0.01)。PNH组血清su鄄PAR水平显著升高(P<0.01),PNH患者伴血栓形成组与不伴血栓形成组比较,前者外周血CD87+粒细胞比例明显降低,血清su鄄PAR水平显著升高(P<0.01)。PNH患者血清su鄄PAR与CD87+粒细胞百分率呈负相关。结论:PNH患者外周血CD87+粒细胞百分率显著降低,血清su鄄PAR水平明显增高,与血栓形成并发症相关。以流式细胞术检测粒细胞CD87及血清su鄄PAR,有助于PNH的诊断及监测血栓形成的病情变化。 Objective: To investigate the expression of urokinase-type plasminogen activator receptor (u-PAR, CD87) on the peripheral blood granulocytes and the soluble u-PAR (su-PAR) level in serum from patients with paroxysmal nocturnal hemoglobinuria (PNH) and to analyze its clinical implications. Methods: Twenty-two patients with PNH, 20 patients with simple thrombosis and 20 healthy volunteers were included in this study. The expression of CD87 on peripheral blood granulocytes were analyzed with flow cytometry. Serum su-PAR was assayed by enzyme-linked immunoadsorbent assay (ELISA). Results: All the fraction of CD87+ granulocytes in peripheral blood of 20 healthy volunteers was more than 90%. The expression of CD87 in 22 patients with PNH decreased significantly and the level of serum su-PAR increased. In the 22 patients with PNH, the fraction of CD87+ granulocytes decreased significantly and the serum level of su-PAR elevated significantly in patients with thrombosis than in patients without thrombosis. The serum level of su-PAR was negatively correlated to the percentage of CD87+ granulocytes in patients with PNH. Conclusion: In patients with PNH, the expression of CD87 in granulocytes decreases remarkably and the serum level of su-PAR increases significantly. Flow cytometric analysis of CD87 on the peripheral blood granulocytes and detection of su-PAR are of value in diagnosis of PNH and helpful for monitoring thrombosis.
出处 《山东大学学报(医学版)》 CAS 2004年第4期409-412,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助课题(Y2000G07)
关键词 血红蛋白尿 阵发性 尿纤溶酶原激活物 抗原 CD87 Hemoglobinuria,paroxysmal Urokinase-type plasminogen activator Antigen,CD87
  • 相关文献

参考文献8

  • 1Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria[J]. Blood, 1995, 86:3277-3286.
  • 2Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR[J]. Stem Cells, 1997, 15(6): 398-408.
  • 3Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis [J]. Arterioscler Thromb Vasc Biol, 2001, 21 (7):1104-1117.
  • 4Ronne E, Pappot H, Grondahl-Hansen J, et al. The receptor for urokinase plasmino-gen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria[J].Br J Haematol, 1995, 89(3): 576-581.
  • 5Ploug M, Eriksen J, Plesner T, et al. Soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria [J]. Eur J Biochem, 1992,208(2): 397-404.
  • 6Socie G, Mary JY, Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors[J]. French Society of Haematology Lancet, 1996, 348(9027): 573-577.
  • 7乐晓峰,刘尔坤.我国阵发性睡眠性血红蛋白尿症的临床特点:658例临床分析[J].中华血液学杂志,1989,10(11):570-571. 被引量:4
  • 8徐开林,潘秀英,刘艳,姚仁南.阵发性睡眠性血红蛋白尿症患者血栓前状态的研究[J].中华血液学杂志,1997,18(10):525-528. 被引量:3

二级参考文献6

  • 1中华血液学杂志,1988年,9期,122页
  • 2杨天楹,中华内科杂志,1965年,10期,866页
  • 3王建中,现代实验诊断学手册,1995年,249页
  • 4徐开林,中华血液学杂志,1992年,13卷,534页
  • 5张之南,中华血液学杂志,1990年,11卷,606页
  • 6蔺竹亭,中华血液学杂志,1989年,10卷,592页

共引文献4

同被引文献30

  • 1Ronne E,Pappot H,Grondahl-Hansen J,et al.The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria.Br J Haematol,1995,89:576-81.
  • 2Ploug M,Eriksen J,Plesner T,et al.A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.Eur J Biochem,1992,208:397-404.
  • 3Van Bijnen ST, Van Heerde WL, Muus P. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost,2012,10 : 1-10.
  • 4Helley D, de Latour RP, Porcher R, et al. Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab. Haematologica, 2010, 95: 574-581.
  • 5Basavaraj MG, Gruber FX, Sovershaev M, et al. The role of TFPIin regulation of TF-indueed thrombogenicity on the surface of human monocytes. Thromb Res, 2010,126 : 418-425.
  • 6Kozuma Y, Sawabata Y, Takei Y, et al. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. BrJ Haematol,2011,152 :631-639.
  • 7Affy M, Eissa M, Salah HE,et al. Role of urokinase plasminogen activator receptor ( CD87 ) as a prognostic marker in acute myeloid leukemia. Med Oncol,2012,29:2063-2069.
  • 8Sloand EM, Pfannes L, Scheinberg P, et al. Increased soluble urokinase plasminogen activator receptor ( suPAR ) is associated with thrombosis and inhibition of plasmin generation in paroxysmal noctumal hemoglobinuria(PNH) patients. Exp Hematd ,2008,36 : 1616-1624.
  • 9Ploug M, Eriksen J, Plesner T, et al. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripherak blood leukocytes from patients with paroxysmal noctural bemoglobinuria. Eur J Biochcm, 1992, 208 : 397-404.
  • 10Qin X, Ha W, Song W, et al. Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice. Am J Hematol, 2009,84: 221- 227.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部